Our paper published in Science Translational Medicine last week, titled: “Targeting therapeutic nanoparticles to the glioblastoma resection margin by harnessing postoperative blood-brain barrier disruption” is capturing widespread attention from mass media. From print media, to broadcast and digital, all outlets have highlighted the significance of the discovery as a new window of opportunity to treat aggressive, resectable brain cancers.